Early Fix of Leaky Mitral Valve After Heart Attack
Part of Heart & circulation clinical trials.
This trial tests an early, minimally invasive procedure to fix a leaky mitral valve using a catheter (a thin tube) after a heart attack. The goal is to see if fixing the valve early can help patients recover better and avoid more serious heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have moderate to severe or severe mitral regurgitation (a leaky heart valve) that started after a heart attack.
- You are older than 18 years.
- You do NOT have mitral regurgitation caused by a ruptured papillary muscle (a different type of leak).
- Your heart’s pumping strength (ejection fraction) is higher than 25%.
- You are not scheduled for coronary artery bypass surgery (CABG).
- You are not currently in cardiogenic shock (very low blood pressure from severe heart failure).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a catheter-based procedure to repair a leaking mitral valve in people who are in severe heart shock and need medication support. The goal is to reduce the valve leak and see if it helps patients stabilize and recover.
This trial compares a less invasive catheter procedure to the standard surgical operation to treat “secondary” leaking of the mitral valve. It may help people with significant valve leak decide which approach works better for reducing symptoms and heart strain.
This study tests a minimally invasive procedure (edge-to-edge repair) for people whose mitral valve leaks because of an enlarged upper heart chamber (atrial functional mitral regurgitation). The goal is to see if this clip repair improves symptoms and outcomes compared with standard medical therapy alone.
This trial tests a minimally invasive procedure to fix a leaky mitral valve in people with ATTR-CM. The procedure, called edge-to-edge repair, uses a catheter to clip the valve, which may improve symptoms and quality of life.
This trial studies a minimally invasive device meant to fix a badly leaking mitral valve (mitral regurgitation) without open-heart surgery. It may be an option if you’re considered too high-risk for standard surgery and your heart anatomy fits the device.
This trial tests a minimally invasive procedure to repair a leaky mitral valve in people with a specific type of heart failure. The goal is to see if the procedure, called transcatheter edge-to-edge repair (TEER), is safe and effective in reducing symptoms and improving heart function.
Hear when a new Acute Mitral Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.